Excerpted from Conquer Prostate Cancer: How Medicine, Faith, Love and Sex Can Renew Your Life, by Rabbi Edgar Weinsberg, www.ConquerProstateCancer.com
• Each year prostate cancer strikes an estimated 670,000 men around the world and causes 221,000 deaths.
• Nearly 200,000 Americans are diagnosed with prostate cancer each year, and about 28,000 die of advanced prostate disease annually.
• About one-third of newly diagnosed American prostate cancer patients are Baby Boomers in their early forties to early sixties.
• The annual diagnosis rate worldwide includes 300,000 Europeans, 35,000 in the United Kingdom (10,000 deaths), 24,700 Canadians (4,300 deaths) and 12,000 Australians (2,700 deaths). Asian countries report fewer prostate cancer incidents than Western countries.
• Prostate cancer is the leading cancer, after skin cancer, among men and is generally the second leading cancer, after lung cancer, to cause men's deaths.
• Of American men diagnosed with prostate cancer, 80% have cancer that is localized in the prostate, and the minority have advanced, aggressive malignancies.
• In the United States there are 2 million prostate cancer survivors who have been cured of this disease, mostly because they were patients with localized cancer when first treated.
• This cancer and its treatment can threaten not only men's health and longevity, but the quality of their lives. About 60% (give or take 10%) of patients suffer from impotence after surgery or radiotherapy within 5 years of treatment, becoming part of the 15 to 30 million Americans who have ED, and 5% remain incontinent. In the process of their illness and treatment side effects, patients tend to experience pain or stress and may have difficulty renewing their lives. (Statistics updated since the book was published.)
• Another 15 million Americans have a related but far less dangerous condition, benign prostate enlargement or hyperplasia (BPH). Like prostate cancer, it affects a man's urinary stream and potency. While a benign prostate condition is not necessarily followed by a malignancy, this often occurs.
• Several major prostate cancer support, education and research funding organizations, based in the United States, work on behalf of men with prostate cancer. Several other large organizations, including the American Cancer Society and the Wellness Community, also support prostate cancer patients and survivors, here or abroad, along with many others confronted by various types of cancer.
• Each year prostate cancer strikes an estimated 670,000 men around the world and causes 221,000 deaths.
• Nearly 200,000 Americans are diagnosed with prostate cancer each year, and about 28,000 die of advanced prostate disease annually.
• About one-third of newly diagnosed American prostate cancer patients are Baby Boomers in their early forties to early sixties.
• The annual diagnosis rate worldwide includes 300,000 Europeans, 35,000 in the United Kingdom (10,000 deaths), 24,700 Canadians (4,300 deaths) and 12,000 Australians (2,700 deaths). Asian countries report fewer prostate cancer incidents than Western countries.
• Prostate cancer is the leading cancer, after skin cancer, among men and is generally the second leading cancer, after lung cancer, to cause men's deaths.
• Of American men diagnosed with prostate cancer, 80% have cancer that is localized in the prostate, and the minority have advanced, aggressive malignancies.
• In the United States there are 2 million prostate cancer survivors who have been cured of this disease, mostly because they were patients with localized cancer when first treated.
• This cancer and its treatment can threaten not only men's health and longevity, but the quality of their lives. About 60% (give or take 10%) of patients suffer from impotence after surgery or radiotherapy within 5 years of treatment, becoming part of the 15 to 30 million Americans who have ED, and 5% remain incontinent. In the process of their illness and treatment side effects, patients tend to experience pain or stress and may have difficulty renewing their lives. (Statistics updated since the book was published.)
• Another 15 million Americans have a related but far less dangerous condition, benign prostate enlargement or hyperplasia (BPH). Like prostate cancer, it affects a man's urinary stream and potency. While a benign prostate condition is not necessarily followed by a malignancy, this often occurs.
• Several major prostate cancer support, education and research funding organizations, based in the United States, work on behalf of men with prostate cancer. Several other large organizations, including the American Cancer Society and the Wellness Community, also support prostate cancer patients and survivors, here or abroad, along with many others confronted by various types of cancer.